GENOME CAPITAL

We are company builders passionate about innovative BioTech and HealthTech
About Us
Our team is a rare combination of tech enterpreneurs, PhD scientists and M&A dealmakers with an exceptional investment experience including work in teams who identified and raised 4 unicorns and leadership of 3,000+ medtech founders' community from Emerging markets that is part of a unique ecosystem raised more than 30 unicorns.
About Us
Our team is a rare combination of tech enterpreneurs, PhD scientists and M&A dealmakers with an exceptional investment experience including work in teams who identified and raised 4 unicorns and leadership of 3,000+ medtech founders' community from Emerging markets that is part of a unique ecosystem raised more than 30 unicorns.
Our Focus
We invest capital and expertise in talented teams and exciting science and technology.
We invest capital and expertise in talented teams and exciting science and technology.
Our focus

Healthcare costs continue to grow at a rapid pace. Genome Capital believes that now is the right time to invest in:

Healthcare costs continue to grow at a rapid pace. Genome Capital believes that now is the right time to invest in:

Robotic Medical devices
AI diagnostic
Telemedicine
AI drug discovery
Bioimplants
  • Robotic Medical devices
  • AI diagnostic
  • Telemedicine
  • AI drug discovery
  • Bioimplants

That can expand the foundations of medical practice, improve the quality of life and provide high returns for our investors.

That can expand the foundations of medical practice, improve the quality of life and provide high returns for our investors.

Impact
Impact
We believe that high financial and societal returns can coexist.
More than 5 bn people in emerging markets have limited access to medical services due to shortage of doctors in the region, lack of good infrastructure, and high cost of services and medicines.
New technologies in Life Science, IT and Robotics can change the rules of the game!
We believe that high financial and societal returns can coexist.
More than 5 bn people in emerging markets have limited access to medical services due to shortage of doctors in the region, lack of good infrastructure, and high cost of services and medicines.
New technologies in Life Science, IT and Robotics can change the rules of the game!
Our Team
  • Sveta Gavrilova
    Managing Partner
    • 12 years in HealthTech VC & PE, incl 7 years in Rusnano ($500m AUM, 8 exits, 1 unicorn)
    • 7 years in KPMG audit
    • Principal of 3,000-member global tech founders' communities
    • Graduated in Economics & Law (MSU, MSAL)
    • Founders Institute: VC fund manager program (USA); ACCA prof (UK)
    LinkedIn
  • Anton Melnikov
    Managing Partner
    • 12+ year in C-level and internation Business Development for HealthTech companies and distributors
    • Founder of Income- medtech technology transfer hub in the Middle East
    • 400+ HealthTech Startups mentor in Skolkovo acceleration program
    • 5+ years in supervisery Board member for Siberian science cluster
    • MBA, Bachelor of Technology (NSU)

    LinkedIn
  • Veronika Aksenova
    Venture Partner
    • Director of the acceleration programs for HealthTech (Rehabilitaion) startups at Skolkovo
    • PhD in molecular biology (France)
    • 6+ years of experience in R&D
    • BioTech VC Skolkovo
    • 4+ Leading onco products director at Roche
    • Mentor in Founder Institute for Impact and Sustainability startups
    • BioTech leader of 5,000-member tech founders' community
    LinkedIn
  • Marina Sol
    Venture Partner
    • Founder of 3 startups in digital medicine, 1 - exit, sale to Big Pharma
    • 4 years at Sanofi - Head of Multichannel Marketing, Eurasia-Middle East-Africa
    • 5 years at Valenta Pharmaceuticals - Director of Digital Marketing
    • Stanford University- Digital Health Product Development
    • Saint Petersburg University of Engineering and Economics
    LinkedIn
Our Team
  • Sveta Gavrilova
    Managing Partner
    • 10+ years in HealthTech VC & PE, incl 7 years in Rusnano ($500m AUM, 8 exits, 1 unicorn)
    • 7 years in KPMG audit
    • Principal of 3,000-member global tech founders' communities
    • Graduated in Economics & Law (MSU, MSAL)
    • Founders Institute: VC fund manager program (USA); ACCA prof (UK)
    LinkedIn
  • Anton Melnikov
    Managing Partner
    • 12+ year in C-level and internation Business Development for HealthTech companies and distributors
    • Founder of Income- medtech technology transfer hub in the Middle East
    • 400+ HealthTech Startups mentor in Skolkovo acceleration program
    • 5+ years in supervisery Board member for Siberian science cluster
    • MBA, Bachelor of Technology (NSU)


    LinkedIn
  • Veronika Aksenova
    Venture Partner
    • Director of the acceleration programs for HealthTech (Rehabilitaion) startups at Skolkovo
    • PhD in molecular biology (France)
    • 6+ years of experience in R&D
    • BioTech VC Skolkovo
    • 4+ Leading onco products director at Roche
    • Mentor in Founder Institute for Impact and Sustainability startups
    • BioTech leader of 5,000-member tech founders' community
    LinkedIn
  • Marina Sol
    Venture Partner
    • Founder of 3 startups in digital medicine, 1 - exit, sale to Big Pharma
    • 4 years at Sanofi - Head of Multichannel Marketing, Eurasia-Middle East-Africa
    • 5 years at Valenta Pharmaceuticals - Director of Digital Marketing
    • Stanford University- Digital Health Product Development
    • Saint Petersburg University of Engineering and Economics
    LinkedIn
News
    News
      Speak With Us
      Meet the Partners to learn more about GENOME CAPITAL
      Upload your pitchdeck
      Speak With Us
      Meet the Partners to learn more about GENOME CAPITAL.
      Upload your pitchdeck
      Subscribe to the mailing list
      Subscribe to the mailing list
      Veronika Aksenova
      vaksenova@genomecapital.vc
      Svetlana Gavrilova
      sgavrilova@genomecapital.vc
      Contacts